Major Investment from Genome Canada to Help Advance ClarityDX Prostate Adoption Across Canada
The funding to propel widespread adoption and integration of innovative prostate cancer diagnostic test into Canadian healthcare.
June 26, 2025
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the
June 18, 2025
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors.
June 17, 2025
